
- Modern Retina Summer 2021
- Volume 1
- Issue 1
Analyzing clinical results of dexamethasone implant effect on macular thickness
Daniel F. Kiernan, MD, discusses key findings of a clinical study analyzing the effect of dexamethasone intracameral drug-delivery suspension on macular thickness based on OCT testing following vitreoretinal surgery.
Daniel F. Kiernan, MD, a vitreoretinal surgeon at The Eye Associates, Sarasota, Florida, discusses the highlights of his 2021 ARVO virtual presentation on the effect of dexamethasone intracameral drug-delivery suspension on macular thickness based on optical coherence tomography (OCT) testing following vitreoretinal surgery.
Articles in this issue
about 4 years ago
Pediatric ophthalmologists target inherited retinal diseasesabout 4 years ago
Gaining a greater understanding of AMDNewsletter
Keep your retina practice on the forefront—subscribe for expert analysis and emerging trends in retinal disease management.